CVA Family Office’s Argan AGX Stock Holding History

CVA Family Office’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.19K	Buy	9 +2	+29%	+$1.33K	﹤0.01%	1136
2026 Q1	$3.81K	Buy	+7	New	+$2.85K	﹤0.01%	1332

Other funds holding AGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

CVA Family Office's AGX Position: Q2 2026 in Review

CVA Family Office increased its Argan (AGX) stake by 29% in Q2 2026, buying an estimated $1.33K and bringing the position to 9 shares worth $7.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

CVA Family Office first reported a position in AGX in Q1 2026 and has held it in 2 quarters since. 562 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

CVA Family Office held 9 shares of Argan worth $7.19K as of Q2 2026.
CVA Family Office bought 2 Argan shares in Q2 2026, an estimated $1.33K.
Argan made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1136 holding.
CVA Family Office first reported a position in Argan in Q1 2026 and has held it in 2 quarters since.
562 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.